Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01850706 · ClinicalTrials.gov registry record

UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
50
Enrollment target

NCT01850706 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01850706 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The purpose of this study is to find a noninvasive test to help physicians diagnose detrusor overactivity (DO), to use this urine test to help diagnose bladder problems, determine if treatments are working, and determine if patients are good candidates for interventions like sacral neuromodulation/Interstim Therapy.

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2011-08
Est. Completion 2016-03

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT01850706

The ClinicalTrials.gov registry entry for NCT01850706 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01850706 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01850706 about?

NCT01850706 is a clinical study titled "UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation". The purpose of this study is to find a noninvasive test to help physicians diagnose detrusor overactivity (DO), to use this urine test to help diagnose bladder problems, determine if treatments are working, and determine if patients are good candidates for interventions like sacral neuromodulation/I...

What is the current status of trial NCT01850706?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2011-08. Estimated completion is 2016-03.

Who is sponsoring clinical trial NCT01850706?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.